Publications

  1. Skartsis N, Muller YD, Ferreira LMR. Regulatory T cell homeostasis: Requisite signals and implications for clinical development of biologics. Clin Immunol. 2023 Jan; 246:109201 Epub 2022 Dec 05
    View PubMed
  2. Brar S, Berry R, Raval AD, Tang Y, Vincenti F, Skartsis N. Outcomes among CMV-mismatched and highly sensitized kidney transplants recipients who develop neutropenia. Clin Transplant. 2022 Apr; 36 (4):e14583 Epub 2022 Jan 15
    View PubMed
  3. Skartsis N, Ferreira LMR, Tang Q. The dichotomous outcomes of TNFalpha signaling in CD4(+) T cells. Front Immunol. 2022; 13:1042622 Epub 2022 Nov 16
    View PubMed
  4. Warshauer JT, Belk JA, Chan AY, Wang J, Gupta AR, Shi Q, Skartsis N, Peng Y, Phipps JD, Acenas D, Smith JA, Tamaki SJ, Tang Q, Gardner JM, Satpathy AT, Anderson MS. A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance. J Exp Med. 2021 Aug 2; 218 (8) Epub 2021 June 11
    View PubMed
  5. Muller YD, Ferreira LMR, Ronin E, Ho P, Nguyen V, Faleo G, Zhou Y, Lee K, Leung KK, Skartsis N, Kaul AM, Mulder A, Claas FHJ, Wells JA, Bluestone JA, Tang Q. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance. Front Immunol. 2021; 12:686439 Epub 2021 Sept 20
    View PubMed
  6. Skartsis N, Peng Y, Ferreira LMR, Nguyen V, Ronin E, Muller YD, Vincenti F, Tang Q. IL-6 and TNFalpha Drive Extensive Proliferation of Human Tregs Without Compromising Their Lineage Stability or Function. Front Immunol. 2021; 12:783282 Epub 2021 Dec 23
    View PubMed
  7. Schumann K, Raju SS, Lauber M, Kolb S, Shifrut E, Cortez JT, Skartsis N, Nguyen VQ, Woo JM, Roth TL, Yu R, Nguyen MLT, Simeonov DR, Nguyen DN, Targ S, Gate RE, Tang Q, Bluestone JA, Spitzer MH, Ye CJ, Marson A. Functional CRISPR dissection of gene networks controlling human regulatory T cell identity. Nat Immunol. 2020 Nov; 21 (11):1456-1466 Epub 2020 Sept 28
    View PubMed
  8. Skartsis N, Martinez L, Duque JC, Tabbara M, Velazquez OC, Asif A, Andreopoulos F, Salman LH, Vazquez-Padron RI. c-Kit signaling determines neointimal hyperplasia in arteriovenous fistulae. Am J Physiol Renal Physiol. 2014 Nov 1; 307 (9):F1095-104 Epub 2014 Sept 03
    View PubMed
  9. Azzi J, Skartsis N, Mounayar M, Magee CN, Batal I, Ting C, Moore R, Riella LV, Ohori S, Abdoli R, Smith B, Fiorina P, Heathcote D, Bakhos T, Ashton-Rickardt PG, Abdi R. Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells. J Immunol. 2013 Sep 1; 191 (5):2319-27 Epub 2013 Aug 02
    View PubMed
  10. Tang L, Azzi J, Kwon M, Mounayar M, Tong R, Yin Q, Moore R, Skartsis N, Fan TM, Abdi R, Cheng J. Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A. J Transplant. 2012; 2012:896141 Epub 2012 Mar 29
    View PubMed
  11. Manning E, Skartsis N, Orta AM, Velazquez OC, Liu ZJ, Asif A, Salman LH, Vazquez-Padron RI. A new arteriovenous fistula model to study the development of neointimal hyperplasia. J Vasc Res. 2012; 49 (2):123-31 Epub 2012 Jan 13
    View PubMed
  12. Skartsis N, Manning E, Wei Y, Velazquez OC, Liu ZJ, Goldschmidt-Clermont PJ, Salman LH, Asif A, Vazquez-Padron RI. Origin of neointimal cells in arteriovenous fistulae: bone marrow, artery, or the vein itself? Semin Dial. 2011 Mar-Apr; 24 (2):242-8
    View PubMed
  13. Levi DM, Tzakis A, Martin P, Nishida S, Island E, Moon J, Selvaggi G, Tekin A, Madrazo B, Narayanan G, Garcia M, Feun L, Tryphonopoulos P, Skartsis N, Livingstone A.. Liver Transplantation for Hepatocellular Carcinoma in the MELD Era. Journal of the American College of Surgeons. 2010.